Effects of Arousal and Stress in Anxiety

Sponsor
National Institute of Mental Health (NIMH) (NIH)
Overall Status
Completed
CT.gov ID
NCT00026559
Collaborator
(none)
1,530
1
1
258.5
5.9

Study Details

Study Description

Brief Summary

This study has several parts. One part will examine the influence of factors such as personality and past experience on reactions to unpleasant stimuli. Others will examine the effect of personality and emotional and attentional states on learning and memory.

When confronted with fearful or unpleasant events, people can develop fear of specific cues that were associated with these events as well as to the environmental context in which the events occurred via a process called classical conditioning. Classical conditioning has been used to model anxiety disorders, but the relationship between stress and anxiety and conditioned responses remains unclear. This study will examine the relationship between cued conditioning and context conditioning . This study will also explore the acquisition and retention of different types of motor, emotional, and cognitive associative processes during various tasks that range from mildly arousing to stressful.

Condition or Disease Intervention/Treatment Phase
  • Device: Shock Device
  • Device: Auditory Startle Device
N/A

Detailed Description

Objective: Fear and anxiety are adaptive responses to different types of threats. Fear is a short-duration response evoked by explicit threat cues and anxiety a more sustained state of apprehension evoked by unpredictable threat. This protocol studied fear using Pavlovian fear conditioning in two studies. Studies 1 and 3. Study 2 focused on anxiety. Studies 1 and 3 will be discontinued to focus uniquely on the study of anxiety. Specifically, we will examine the interactions between anxiety induced experimentally using verbal threat and cognitive processes. We will seek to 1) characterize the effect of anxiety on key cognitive processes including working memory and attention control and 2) examine the extent to which performance of cognitive tasks distract from anxiety.

Study population: This more-than-minimal-risk protocol will test medically and psychiatrically healthy volunteers aged 18-50. Pregnant or nursing women will be excluded.

Method: Fear and anxiety will be measured using the startle reflex to brief and loud sounds. Fear conditioning will be assessed using shock as unconditioned stimulus. Cognitive performance will be examined during periods of unpredictable shock anticipation.

Outcome measures: The study will include cognitive performance and measure of aversive states, primarily the startle reflex.

Study Design

Study Type:
Interventional
Actual Enrollment :
1530 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Effects of Arousal and Stress on Classical Conditioning
Actual Study Start Date :
Jan 10, 2001
Actual Primary Completion Date :
Jul 28, 2022
Actual Study Completion Date :
Jul 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Threat Conditions

threat of shock and auditory startle

Device: Shock Device
Shock Device

Device: Auditory Startle Device
Auditory Startle Device

Outcome Measures

Primary Outcome Measures

  1. Startle Reflex [study visit]

    startle reflex

  2. Performance on cognitive tasks [study visit]

    performance on cognitive tasks

Secondary Outcome Measures

  1. Cognitive tests [during study visit]

    performance on standard cognitive tests (e.g. working memory capacity

  2. psychological questionnaires [during study visit]

    psychological questionnaires (Spielberger state and trait anxiety)

  3. Skin conductance [during study visit]

    Skin conductance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
  • INCLUSION CRITERIA:

  • Males and females

  • Age 18-50

EXCLUSION CRITERIA:
  • Pregnancy

  • Any current ongoing medical illness

  • Current Axis I disorders

  • Past significant psychiatric disorders (e.g., psychotic disorders) according to DSM-IV

  • Current alcohol or substance abuse according to DSM-IV criteria

  • History of alcohol or substance dependence based on DSM-IV criteria within 6 months prior to screening

  • Current psychotropic medication use

  • Current or past organic central nervous system disorders, including but not limited to seizure disorder or neurological symptoms of the wrist and arms (e.g., carpal tunnel syndrome). The latter exclusion is for shock studies only.

  • Positive urine toxicology screen

  • Employees of NIMH or an immediate family member of a NIMH employee.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland United States 20892

Sponsors and Collaborators

  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Monique Ernst, M.D., National Institute of Mental Health (NIMH)

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00026559
Other Study ID Numbers:
  • 010185
  • 01-M-0185
First Posted:
Nov 12, 2001
Last Update Posted:
Aug 4, 2022
Last Verified:
Jul 28, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by National Institute of Mental Health (NIMH)

Study Results

No Results Posted as of Aug 4, 2022